• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复杂机器学习算法与多变量逻辑回归在类风湿关节炎中预测甲氨蝶呤临床反应不足方面的比较

Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis.

作者信息

Gosselt Helen R, Verhoeven Maxime M A, Bulatović-Ćalasan Maja, Welsing Paco M, de Rotte Maurits C F J, Hazes Johanna M W, Lafeber Floris P J G, Hoogendoorn Mark, de Jonge Robert

机构信息

Department of Clinical Chemistry, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, VUmc, 1081 HV Amsterdam, The Netherlands.

Department of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

出版信息

J Pers Med. 2021 Jan 14;11(1):44. doi: 10.3390/jpm11010044.

DOI:10.3390/jpm11010044
PMID:33466633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7828730/
Abstract

The goals of this study were to examine whether machine-learning algorithms outperform multivariable logistic regression in the prediction of insufficient response to methotrexate (MTX); secondly, to examine which features are essential for correct prediction; and finally, to investigate whether the best performing model specifically identifies insufficient responders to MTX (combination) therapy. The prediction of insufficient response (3-month Disease Activity Score 28-Erythrocyte-sedimentation rate (DAS28-ESR) > 3.2) was assessed using logistic regression, least absolute shrinkage and selection operator (LASSO), random forest, and extreme gradient boosting (XGBoost). The baseline features of 355 rheumatoid arthritis (RA) patients from the "treatment in the Rotterdam Early Arthritis CoHort" (tREACH) and the U-Act-Early trial were combined for analyses. The model performances were compared using area under the curve (AUC) of receiver operating characteristic (ROC) curves, 95% confidence intervals (95% CI), and sensitivity and specificity. Finally, the best performing model following feature selection was tested on 101 RA patients starting tocilizumab (TCZ)-monotherapy. Logistic regression (AUC = 0.77 95% CI: 0.68-0.86) performed as well as LASSO (AUC = 0.76, 95% CI: 0.67-0.85), random forest (AUC = 0.71, 95% CI: 0.61 = 0.81), and XGBoost (AUC = 0.70, 95% CI: 0.61-0.81), yet logistic regression reached the highest sensitivity (81%). The most important features were baseline DAS28 (components). For all algorithms, models with six features performed similarly to those with 16. When applied to the TCZ-monotherapy group, logistic regression's sensitivity significantly dropped from 83% to 69% ( = 0.03). In the current dataset, logistic regression performed equally well compared to machine-learning algorithms in the prediction of insufficient response to MTX. Models could be reduced to six features, which are more conducive for clinical implementation. Interestingly, the prediction model was specific to MTX (combination) therapy response.

摘要

本研究的目的是检验机器学习算法在预测甲氨蝶呤(MTX)反应不足方面是否优于多变量逻辑回归;其次,检验哪些特征对于正确预测至关重要;最后,研究表现最佳的模型是否能特异性识别MTX(联合)治疗的反应不足者。使用逻辑回归、最小绝对收缩和选择算子(LASSO)、随机森林和极端梯度提升(XGBoost)评估反应不足(3个月疾病活动评分28-红细胞沉降率(DAS28-ESR)>3.2)的预测情况。将来自“鹿特丹早期关节炎队列治疗”(tREACH)和U-Act-Early试验的355例类风湿关节炎(RA)患者的基线特征合并进行分析。使用受试者操作特征(ROC)曲线的曲线下面积(AUC)、95%置信区间(95%CI)以及敏感性和特异性比较模型性能。最后,在101例开始托珠单抗(TCZ)单药治疗的RA患者中测试特征选择后表现最佳的模型。逻辑回归(AUC = 0.77,95%CI:0.68-0.86)与LASSO(AUC = 0.76,95%CI:0.67-0.85)、随机森林(AUC = 0.71,95%CI:0.61 = 0.81)和XGBoost(AUC = 0.70,95%CI:0.61-0.81)表现相当,但逻辑回归达到了最高敏感性(81%)。最重要的特征是基线DAS28(组成部分)。对于所有算法,具有6个特征的模型与具有16个特征的模型表现相似。当应用于TCZ单药治疗组时,逻辑回归的敏感性从83%显著降至69%(P = 0.03)。在当前数据集中,逻辑回归在预测MTX反应不足方面与机器学习算法表现相当。模型可以简化为6个特征,这更有利于临床应用。有趣的是,该预测模型对MTX(联合)治疗反应具有特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811e/7828730/91358fccdc22/jpm-11-00044-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811e/7828730/30a2d023f928/jpm-11-00044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811e/7828730/4fb1eb054445/jpm-11-00044-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811e/7828730/91358fccdc22/jpm-11-00044-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811e/7828730/30a2d023f928/jpm-11-00044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811e/7828730/4fb1eb054445/jpm-11-00044-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/811e/7828730/91358fccdc22/jpm-11-00044-g003.jpg

相似文献

1
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis.复杂机器学习算法与多变量逻辑回归在类风湿关节炎中预测甲氨蝶呤临床反应不足方面的比较
J Pers Med. 2021 Jan 14;11(1):44. doi: 10.3390/jpm11010044.
2
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio.早期类风湿关节炎中对甲氨蝶呤临床反应不足的多变量预后预测模型的验证及其在Evidencio中的临床应用
Rheumatol Ther. 2020 Dec;7(4):837-850. doi: 10.1007/s40744-020-00230-7. Epub 2020 Sep 14.
3
Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.开发和验证一个预测多变量模型,以预测类风湿关节炎患者对甲氨蝶呤治疗的临床反应不足。
PLoS One. 2018 Dec 10;13(12):e0208534. doi: 10.1371/journal.pone.0208534. eCollection 2018.
4
Early and Accurate Prediction of Clinical Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis Using Machine Learning.使用机器学习对幼年特发性关节炎中甲氨蝶呤治疗的临床反应进行早期准确预测。
Front Pharmacol. 2019 Oct 7;10:1155. doi: 10.3389/fphar.2019.01155. eCollection 2019.
5
Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis.基于机器学习的类风湿关节炎和强直性脊柱炎患者生物制剂反应预测模型。
Arthritis Res Ther. 2021 Oct 9;23(1):254. doi: 10.1186/s13075-021-02635-3.
6
Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab: Results From a Randomized, Controlled Trial.皮下注射托珠单抗治疗类风湿关节炎患者停用甲氨蝶呤后的持续缓解:一项随机对照试验的结果。
Arthritis Rheumatol. 2018 Aug;70(8):1200-1208. doi: 10.1002/art.40493. Epub 2018 Jun 14.
7
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.托珠单抗联合治疗、单药治疗或甲氨蝶呤单药治疗初治的早期类风湿关节炎患者:随机、安慰剂对照的FUNCTION试验的2年临床和影像学结果
Ann Rheum Dis. 2017 Jul;76(7):1279-1284. doi: 10.1136/annrheumdis-2016-210561. Epub 2017 Apr 7.
8
Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.新诊断类风湿关节炎患者接受达标治疗方案(甲氨蝶呤)后应答不足:临床预测因素的建立与验证。
Ann Rheum Dis. 2018 Sep;77(9):1261-1267. doi: 10.1136/annrheumdis-2018-213035. Epub 2018 May 14.
9
Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis.早期类风湿关节炎中与甲氨蝶呤反应相关的代谢生物标志物的鉴定
J Pers Med. 2020 Dec 10;10(4):271. doi: 10.3390/jpm10040271.
10
Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study.托珠单抗单药治疗类风湿关节炎患者对托珠单抗联合甲氨蝶呤治疗有反应后的疗效:随机 JUST-ACT 研究。
Clin Exp Rheumatol. 2019 May-Jun;37(3):437-444. Epub 2018 Sep 17.

引用本文的文献

1
Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review.人工智能预测类风湿关节炎和脊柱关节炎的治疗反应:一项范围综述
Rheumatol Int. 2025 Apr 7;45(4):91. doi: 10.1007/s00296-025-05825-3.
2
Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis.常见基因变异不影响早期类风湿关节炎甲氨蝶呤治疗结果的临床预测。
J Intern Med. 2025 Jun;297(6):693-701. doi: 10.1111/joim.20087. Epub 2025 Apr 6.
3
Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study.

本文引用的文献

1
EULAR definition of difficult-to-treat rheumatoid arthritis.EULAR 定义的难治性类风湿关节炎。
Ann Rheum Dis. 2021 Jan;80(1):31-35. doi: 10.1136/annrheumdis-2020-217344. Epub 2020 Oct 1.
2
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio.早期类风湿关节炎中对甲氨蝶呤临床反应不足的多变量预后预测模型的验证及其在Evidencio中的临床应用
Rheumatol Ther. 2020 Dec;7(4):837-850. doi: 10.1007/s40744-020-00230-7. Epub 2020 Sep 14.
3
Early Prediction of Clinical Response to Etanercept Treatment in Juvenile Idiopathic Arthritis Using Machine Learning.
用于预测早期类风湿关节炎(RA)未缓解情况的机器学习模型的开发凸显了RAID评分强大的预测重要性——来自北极研究的证据。
Front Med (Lausanne). 2025 Feb 12;12:1526708. doi: 10.3389/fmed.2025.1526708. eCollection 2025.
4
Artificial intelligence for predicting treatment responses in autoimmune rheumatic diseases: advancements, challenges, and future perspectives.人工智能在预测自身免疫性风湿病治疗反应中的应用:进展、挑战和未来展望。
Front Immunol. 2024 Oct 22;15:1477130. doi: 10.3389/fimmu.2024.1477130. eCollection 2024.
5
Towards Personalized Medicine in Rheumatoid Arthritis.迈向类风湿关节炎的个性化医疗
Open Access Rheumatol. 2024 May 18;16:89-114. doi: 10.2147/OARRR.S372610. eCollection 2024.
6
Rheumatoid arthritis patients' perspective on the use of prediction models in clinical decision-making.类风湿关节炎患者对预测模型在临床决策中应用的看法。
Rheumatology (Oxford). 2025 Mar 1;64(3):1045-1051. doi: 10.1093/rheumatology/keae202.
7
Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parameters.预测类风湿关节炎患者对抗肿瘤坏死因子治疗的反应:一种利用细胞因子谱和常规临床实践参数的人工智能驱动模型。
Heliyon. 2023 Nov 28;10(1):e22925. doi: 10.1016/j.heliyon.2023.e22925. eCollection 2024 Jan 15.
8
Corticosteroid treatment prediction using chest X-ray and clinical data.利用胸部X光和临床数据进行皮质类固醇治疗预测。
Comput Struct Biotechnol J. 2023 Dec 7;24:53-65. doi: 10.1016/j.csbj.2023.11.057. eCollection 2024 Dec.
9
Prevalence of wound infections and postoperative complications after total elbow arthroplasty for rheumatoid arthritis: A meta-analysis.类风湿性关节炎全肘关节置换术后伤口感染及术后并发症的患病率:一项荟萃分析。
Int Wound J. 2023 Oct 22;21(2). doi: 10.1111/iwj.14451.
10
Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis.早期类风湿关节炎患者中与甲氨蝶呤治疗效果相关的单核苷酸多态性的鉴定。
Front Pharmacol. 2022 Nov 17;13:1075603. doi: 10.3389/fphar.2022.1075603. eCollection 2022.
使用机器学习对幼年特发性关节炎患者依那西普治疗的临床反应进行早期预测
Front Pharmacol. 2020 Jul 31;11:1164. doi: 10.3389/fphar.2020.01164. eCollection 2020.
4
Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab.C 反应蛋白基线水平和早期变化对托珠单抗治疗类风湿关节炎患者后续临床结局的影响。
Ann Rheum Dis. 2020 Jul;79(7):874-882. doi: 10.1136/annrheumdis-2019-215987. Epub 2020 May 5.
5
Applied machine learning and artificial intelligence in rheumatology.机器学习与人工智能在风湿病学中的应用。
Rheumatol Adv Pract. 2020 Feb 19;4(1):rkaa005. doi: 10.1093/rap/rkaa005. eCollection 2020.
6
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.EULAR 推荐的类风湿关节炎治疗策略:2019 年更新版(使用合成和生物疾病修正抗风湿药物)
Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22.
7
Machine learning in rheumatology approaches the clinic.机器学习在风湿病学领域正走向临床应用。
Nat Rev Rheumatol. 2020 Feb;16(2):69-70. doi: 10.1038/s41584-019-0361-0.
8
Early and Accurate Prediction of Clinical Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis Using Machine Learning.使用机器学习对幼年特发性关节炎中甲氨蝶呤治疗的临床反应进行早期准确预测。
Front Pharmacol. 2019 Oct 7;10:1155. doi: 10.3389/fphar.2019.01155. eCollection 2019.
9
Machine Learning to Predict Anti-Tumor Necrosis Factor Drug Responses of Rheumatoid Arthritis Patients by Integrating Clinical and Genetic Markers.基于临床和遗传标志物的机器学习预测类风湿关节炎患者抗肿瘤坏死因子药物反应。
Arthritis Rheumatol. 2019 Dec;71(12):1987-1996. doi: 10.1002/art.41056. Epub 2019 Nov 4.
10
Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients.基线较高的全血白细胞 DNA 甲基化与早期 RA 患者对 MTX 的无反应相关。
Arthritis Res Ther. 2019 Jun 26;21(1):157. doi: 10.1186/s13075-019-1936-5.